The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Overcome Fear & Misinformation: Solutions for Women with Inflammatory Arthritis Considering Pregnancy

Overcome Fear & Misinformation: Solutions for Women with Inflammatory Arthritis Considering Pregnancy

May 20, 2022 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

During pregnancy and lactation, some women choose to endure active inflammatory arthritis rather than take disease-modifying drugs. Mehret Birru Talabi, MD, PhD, assistant professor of rheumatology and clinical immunology of the University of Pittsburgh, Pa., and colleagues found some women are concerned about medication safety during pregnancy and while breastfeeding their baby.

You Might Also Like
  • A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes
  • Pregnancy Outcomes in Women with Idiopathic Inflammatory Myositis
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
Also By This Author
  • BAFF: A Fulcrum Between Resistance to Infection & Autoimmunity

In results of their mixed-methods study, published in the July 2021 issue of ACR Open Rheumatology, Birru Talabi et al. report that patients’ health providers gave them conflicting advice about medication safety during pregnancy and lactation—advice which, in some cases, undermined their trust in their providers.1 The authors emphasize the high rate of peripartum exposure to the fetotoxic drug, methotrexate, underscores the need for better family planning care for women with childbearing potential.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators performed their study in collaboration with ArthritisPower, a patient-powered research network, and CreakyJoints, its online partner community. The organizations helped develop and disseminate a survey among community members with inflammatory arthritis who had at least one pregnancy after their diagnosis with a rheumatic illness. Additionally, the investigators used thematic analysis to evaluate the participants’ (N=66) free text responses. The women in the study were 40 years old on average, and 19 of their pregnancies ended in fetal loss.

Misinformation & Inconsistent Advice

Dr. Birru Talabi

According to Dr. Birru Talabi, for years rheumatologists have observed that rheumatoid arthritis (RA) can improve during pregnancy. However, more recent evidence suggests many women still experience some disease activity during pregnancy. The study revealed that although pregnant women are not experiencing full relief from their symptoms, 80% discontinued even safe medications in preparation for pregnancy or during pregnancy and lactation. The findings were consistent with previous research showing that many patients stop filling prescriptions during pregnancy.2 The results also prompt concern that a patient’s fear of the medications harming their fetus may lead to disability or damage from inflammatory arthritis that can extend beyond pregnancy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The study revealed that although some patients discontinue medications out of fear and a lack of information, other patients discontinue medications because of misinformation. In part, this discontinuation occurs because decisions to continue medications during pregnancy were influenced by their perceptions of safety and advice from healthcare providers other than their rheumatologists.

“Misinformation, in general, has consequences,” says Dr. Birru Talabi, adding, “This discontinuation of safe medications may, unfortunately, cause a lot of physical suffering for patients with inflammatory arthritis.”

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: ACR Open Rheumatology, breastfeeding, misinformation, pregnancy, pregnant women, reproductive health, Women

You Might Also Like:
  • A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes
  • Pregnancy Outcomes in Women with Idiopathic Inflammatory Myositis
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
  • Improved Pregnancy Outcomes for Women with SLE

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)